Jazz Pharmaceuticals plc (JAZZ) › Operating IncomeJazz Pharmaceuticals plc (JAZZ) — Operating IncomeAnnual figures by period end, from SEC filings.2009-12-31: $15.93M2010-12-31: $57.79M2011-12-31: $127.83M2012-12-31: $197.84M2013-12-31: $340.31M2014-12-31: $195.59M2015-12-31: $508.22M2016-12-31: $591.65M2017-12-31: $528.84M2018-12-31: $614.84M2019-12-31: $532.37M2020-12-31: $378.07M2021-12-31: $170.28M2022-12-31: -$65.53M2023-12-31: $578.58M2024-12-31: $716.63M2025-12-31: -$430.24M-$430.24M2009-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$430.24M-160.0%2026-02-24From 2025-01-012024-12-31$716.63M+23.9%2026-02-24From 2024-01-012023-12-31$578.58M—2026-02-24From 2023-01-012022-12-31-$65.53M-138.5%2025-02-26From 2022-01-012021-12-31$170.28M-55.0%2024-02-28From 2021-01-012020-12-31$378.07M-29.0%2023-03-01From 2020-01-012019-12-31$532.37M-13.4%2022-03-01From 2019-01-012018-12-31$614.84M+16.3%2021-02-23From 2018-01-012017-12-31$528.84M-10.6%2020-02-25From 2017-01-012016-12-31$591.65M+16.4%2019-02-26From 2016-01-012015-12-31$508.22M+159.8%2018-02-27From 2015-01-012014-12-31$195.59M-42.5%2017-02-28From 2014-01-012013-12-31$340.31M+72.0%2016-02-23From 2013-01-012012-12-31$197.84M+54.8%2015-02-24From 2012-01-012011-12-31$127.83M+121.2%2014-02-25From 2011-01-012010-12-31$57.79M+262.8%2013-02-26From 2010-01-012009-12-31$15.93M—2012-02-28From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)